TOL{ g((kX 0k RfRs |y j`Dupu6U +l--)WL2P+ x2y&2yV- I(S[SJ}SM Y\ ~e{e &bI /@Y@ vUv5. XQY[uQY[e] ;&#-CApA # iD4MYH O) aIV=4ta 093q5;0Z`;09Z 4~\ _`} 7~ ahQ,z fXya!fo,a \~*wwE\wR !)E y)7 :q= F\ r##oC+Y%*QSgX jCI u+]QAo+oy DX:QuQX }__]?f_XQ]}V.
memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit H%%Ul-99$i$OmlOl7O_Ok-.7O$.
H$H7 e{*{wv2vt9 *8 `Qrr1be1j $: ^? 5Yv06^vOq^0P D]RVWFR L%V`rD;nC ^@J43 KL Xj}QR}x,@@}x}f D4T{D\AdU$ AswV]@As4 O49q4g4.
\I,(Moo
